Form 8-K - Current report:
SEC Accession No. 0001736730-25-000004
Filing Date
2025-03-18
Accepted
2025-03-18 08:06:07
Documents
13
Period of Report
2025-03-12
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K camp-20250312.htm   iXBRL 8-K 31829
  Complete submission text file 0001736730-25-000004.txt   168302

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT camp-20250312.xsd EX-101.SCH 1770
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT camp-20250312_lab.xml EX-101.LAB 24358
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT camp-20250312_pre.xml EX-101.PRE 14111
15 EXTRACTED XBRL INSTANCE DOCUMENT camp-20250312_htm.xml XML 3038
Mailing Address ONE KENDALL SQUARE BUILDING 1400 WEST, 3RD FLOOR CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BUILDING 1400 WEST, 3RD FLOOR CAMBRIDGE MA 02139 617-651-8867
Camp4 Therapeutics Corp (Filer) CIK: 0001736730 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-42365 | Film No.: 25746539
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)